Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups in the healthcare industry. As there is a large number of startups working on a wide variety of solutions, we decided to share our insights with you. So, let’s take a look at promising regenerative medicine solutions.
Heat Map: 4 Top Regenerative Medicine Startups impacting Healthcare
For our 4 picks of regenerative medicine startups, we used a data-driven startup scouting approach to identify the most relevant solutions globally. The Global Startup Heat Map below highlights 4 interesting examples out of 720 relevant solutions. Depending on your specific needs, your top picks might look entirely different.
Click to enlarge
KidneyCure – Stem Cell Therapy
Stem cell therapy promotes organ repair and regeneration, thus obviating the need for their replacement. Various treatments involve the extraction of a person’s own stem cells or stem cells from the adult donors with their further injection into damaged tissues or a site of injury. Tel Aviv-based KidneyCure develops proprietary cell therapies aiming to prevent the progression of chronic kidney disease. KidneyCure’s 3D renal cell cluster technology is expected to significantly delay the need for dialysis and transplantation giving millions of patients an opportunity to live longer higher quality lives.
Silk Biomaterials – Tissue Engineering
Tissue engineering combines the principles of material engineering and biomedical sciences to develop bio-artificial tissues and organs that are used as a replacement part to repair or replace damaged or diseased organs. The process generally involves growing various cell types onto three-dimensional scaffolds, which are then implanted into the patient. These scaffolds are carefully designed to allow the cells to develop into tissues that mirror the natural structure and function of a damaged body part. Italian Silk Biomaterials is a MedTech startup developing a technology for the production of medical implantable devices made of silk for the in-vivo regeneration of human tissues. The current project is a silk fibroin-made tissue-engineered graft for vascular procedures (artery bypass, peripheral revascularization, etc.).
AmnioChor – Amniotic Stem Cells Therapy
Amniotic fluid stem cells represent a novel class of pluripotent stem cells with intermediate characteristics between embryonic and adult stem cells, as they are able to differentiate into lineages representative of all three germ layers but do not form tumors when injected in vivo. These characteristics make stem cells, present in the amniotic fluid, promising candidates for tissue engineering and stem cell therapy used to treat different human disorders (tendons and other connective tissues, skin transplantations, speed up healing and wound closure, etc.). Chicago-based AmnioChor is a BioTech company that develops perinatal stem cell and tissue technologies. The company’s AmnioCept technology is used for the recovery of the human placenta, as perinatal tissue and stem cells contribute to the cure in future cellular-based therapies and regenerative medicine.
NovaGenix – Platelet-Rich Plasma Therapy (PRP Injections)
Platelet-rich plasma injections help a body heal faster. PRP injections are becoming more common as a treatment option as studies validate the efficacy of this natural approach. Because the patient is injected only with concentrate from their own blood, PRP therapy avoids safety issues of ensuring donor compatibility when using blood and tissue donation. NovaGenix, a startup from Florida, specializes in bio-identical hormone replacement therapy (BHRT), Platelet Rich Plasma Therapy (PRP) for chronic injuries, facial rejuvenation and hair restoration. The treatment uses the body’s own growth factors taken from the patient’s blood to treat and repair damaged soft and hard tissue and stimulate the wound healing process.
What About The Other 716 Regenerative Medicine Solutions?
While we believe data is key to creating insights it can be easy to be overwhelmed by it. Our ambition is to create a comprehensive overview and provide actionable innovation intelligence for your Proof of Concept (PoC), partnership, or investment targets. The 4 regenerative medicine startups showcased above are promising examples out of 720 we analyzed for this article. To identify the most relevant solutions based on your specific criteria and collaboration strategy, get in touch.
